BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pu J, Wang J, Qin Z, Wang A, Zhang Y, Wu X, Wu Y, Li W, Xu Z, Lu Y, Tang Q, Wei H. IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism. Front Oncol 2020;10:578816. [PMID: 33224879 DOI: 10.3389/fonc.2020.578816] [Cited by in Crossref: 8] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Feng Q, Wang D, Xue T, Lin C, Gao Y, Sun L, Jin Y, Liu D. The role of RNA modification in hepatocellular carcinoma. Front Pharmacol 2022;13:984453. [DOI: 10.3389/fphar.2022.984453] [Reference Citation Analysis]
2 Qin S, Liu G, Jin H, Chen X, He J, Xiao J, Qin Y, Mao Y, Zhao L. The comprehensive expression and functional analysis of m6A modification "readers" in hepatocellular carcinoma. Aging (Albany NY) 2022;14. [PMID: 35963644 DOI: 10.18632/aging.204217] [Reference Citation Analysis]
3 Fang Z, Mei W, Qu C, Lu J, Shang L, Cao F, Li F. Role of m6A writers, erasers and readers in cancer. Exp Hematol Oncol 2022;11:45. [PMID: 35945641 DOI: 10.1186/s40164-022-00298-7] [Reference Citation Analysis]
4 Jia J, Wu S, Jia Z, Wang C, Ju C, Sheng J, He F, Zhou M, He J. Novel insights into m6A modification of coding and non-coding RNAs in tumor biology: From molecular mechanisms to therapeutic significance. Int J Biol Sci 2022;18:4432-51. [PMID: 35864970 DOI: 10.7150/ijbs.73093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Qin Y, Wang CJ, Ye HL, Ye GX, Wang S, Pan DB, Wang J, Shen HJ, Xu SQ. WWP2 overexpression inhibits the antitumor effects of doxorubicin in hepatocellular carcinoma. Cell Biol Int 2022. [PMID: 35880837 DOI: 10.1002/cbin.11856] [Reference Citation Analysis]
6 Zamora-fuentes JM, Hernández-lemus E, Espinal-enríquez J. Oncogenic Role of miR-217 During Clear Cell Renal Carcinoma Progression. Front Oncol 2022;12:934711. [DOI: 10.3389/fonc.2022.934711] [Reference Citation Analysis]
7 Yang F, Hu Z, Guo Z. Small-Molecule Inhibitors Targeting FEN1 for Cancer Therapy. Biomolecules 2022;12:1007. [DOI: 10.3390/biom12071007] [Reference Citation Analysis]
8 Pan X, Huang B, Ma Q, Ren J, Liu Y, Wang C, Zhang D, Fu J, Ran L, Yu T, Li H, Wang X, Yang F, Liang C, Zhang Y, Wang S, Ren J, Li W, Wang Y, Xiao B. Circular RNA circ-TNPO3 inhibits clear cell renal cell carcinoma metastasis by binding to IGF2BP2 and destabilizing SERPINH1 mRNA. Clin Transl Med 2022;12:e994. [PMID: 35876041 DOI: 10.1002/ctm2.994] [Reference Citation Analysis]
9 Yu H, Wang C, Ke S, Bai M, Xu Y, Lu S, Feng Z, Qian B, Xu Y, Zhou M, Li Z, Yin B, Li X, Hua Y, Zhou Y, Pan S, Fu Y, Ma Y. Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma. Front Immunol 2022;13:892750. [DOI: 10.3389/fimmu.2022.892750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Song N, Cui K, Zhang K, Yang J, Liu J, Miao Z, Zhao F, Meng H, Chen L, Chen C, Li Y, Shao M, Zhang J, Wang H. The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research. Front Pharmacol 2022;13:933332. [DOI: 10.3389/fphar.2022.933332] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
11 Zhou Z, Zhu L. Epitranscriptomic analysis of m6A methylome in rats after lumbosacral nerve root avulsion. Epigenomics 2022. [PMID: 35574678 DOI: 10.2217/epi-2022-0127] [Reference Citation Analysis]
12 Zhang Z, Xing Y, Gao W, Yang L, Shi J, Song W, Li T. N6-methyladenosine (m6A) reader IGF2BP2 promotes gastric cancer progression via targeting SIRT1. Bioengineered 2022;13:11541-50. [PMID: 35502827 DOI: 10.1080/21655979.2022.2068920] [Reference Citation Analysis]
13 Chen Z, Hu Y, Jin L, Yang F, Ding H, Zhang L, Li L, Pan T. The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance. Front Pharmacol 2022;13:873030. [PMID: 35462896 DOI: 10.3389/fphar.2022.873030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Liu J, Jiang K. METTL3‐mediated maturation of miR‐589‐5p promotes the malignant development of liver cancer. J Cellular Molecular Medi. [DOI: 10.1111/jcmm.16845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhou L, Li H, Cai H, Liu W, Pan E, Yu D, He S. Upregulation of IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression That Is Related to Cell Proliferation, Metastasis and Tumor-Infiltrating Immune Cells. Front Oncol 2022;12:809589. [PMID: 35299748 DOI: 10.3389/fonc.2022.809589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Zhang T, Zhang S, Zhang S, Huang Y. mAexpress-Reader: prediction of m6A regulated expression genes by integrating m6A sites and reader binding information in specific- context. Methods 2022. [DOI: 10.1016/j.ymeth.2022.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Liu D, Xia A, Wu L, Li S, Zhang K, Chen D. IGF2BP2 promotes gastric cancer progression by regulating the IGF1R-RhoA-ROCK signaling pathway. Cellular Signalling 2022. [DOI: 10.1016/j.cellsig.2022.110313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Zhu XL, Li Q, Shen J, Shan L, Zuo ED, Cheng X. Use of 6 m6A-relevant lncRNA genes as prognostic markers of primary liver hepatocellular carcinoma based on TCGA database. Transl Cancer Res 2021;10:5337-51. [PMID: 35116381 DOI: 10.21037/tcr-21-2440] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
19 Dressler L, Bortolomeazzi M, Keddar MR, Misetic H, Sartini G, Acha-sagredo A, Montorsi L, Wijewardhane N, Repana D, Nulsen J, Goldman J, Pollitt M, Davis P, Strange A, Ambrose K, Ciccarelli FD. Comparative assessment of genes driving cancer and somatic evolution in non-cancer tissues: an update of the Network of Cancer Genes (NCG) resource. Genome Biol 2022;23. [DOI: 10.1186/s13059-022-02607-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
20 Han L, Lei G, Chen Z, Zhang Y, Huang C, Chen W. IGF2BP2 Regulates MALAT1 by Serving as an N6-Methyladenosine Reader to Promote NSCLC Proliferation. Front Mol Biosci 2022;8:780089. [DOI: 10.3389/fmolb.2021.780089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Xia C, Li Q, Cheng X, Wu T, Gao P, Gu Y. Insulin-like growth factor 2 mRNA-binding protein 2-stabilized long non-coding RNA Taurine up-regulated gene 1 (TUG1) promotes cisplatin-resistance of colorectal cancer via modulating autophagy. Bioengineered 2022;13:2450-69. [PMID: 35014946 DOI: 10.1080/21655979.2021.2012918] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
22 Zhang BF, Wu ZH, Deng J, Jin HJ, Chen WB, Zhang S, Liu XJ, Wang WT, Zheng XT. M6A methylation-mediated elevation of SM22α inhibits the proliferation and migration of vascular smooth muscle cells and ameliorates intimal hyperplasia in type 2 diabetes mellitus. Biol Chem 2021. [PMID: 34882999 DOI: 10.1515/hsz-2021-0296] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Zhou W, Wang X, Chang J, Cheng C, Miao C. The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases. Crit Rev Clin Lab Sci 2021;:1-16. [PMID: 34775884 DOI: 10.1080/10408363.2021.2002256] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
24 Banik K, Khatoon E, Hegde M, Thakur KK, Puppala ER, Naidu VGM, Kunnumakkara AB. A novel bioavailable curcumin-galactomannan complex modulates the genes responsible for the development of chronic diseases in mice: A RNA sequence analysis. Life Sci 2021;287:120074. [PMID: 34687757 DOI: 10.1016/j.lfs.2021.120074] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
25 Zhou W, Wang C, Chang J, Huang Y, Xue Q, Miao C, Wu P. RNA Methylations in Cardiovascular Diseases, Molecular Structure, Biological Functions and Regulatory Roles in Cardiovascular Diseases. Front Pharmacol 2021;12:722728. [PMID: 34489709 DOI: 10.3389/fphar.2021.722728] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
26 Qin S, Mao Y, Chen X, Xiao J, Qin Y, Zhao L. The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma. Int J Biol Sci 2021;17:3059-79. [PMID: 34421350 DOI: 10.7150/ijbs.62767] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
27 Dong L, Geng Z, Liu Z, Tao M, Pan M, Lu X. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR. Pathol Res Pract 2021;225:153550. [PMID: 34340128 DOI: 10.1016/j.prp.2021.153550] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
28 Huang J, Shao Y, Gu W. Function and clinical significance of N6-methyladenosine in digestive system tumours. Exp Hematol Oncol 2021;10:40. [PMID: 34246319 DOI: 10.1186/s40164-021-00234-1] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
29 Jin S, Zhu XN, Tan SK. Advances in research of m6A methylation in hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2021; 29(13): 720-725 [DOI: 10.11569/wcjd.v29.i13.720] [Reference Citation Analysis]
30 Li J, Wang F, Liu Y, Wang H, Ni B. N6-methyladenosine (m6A) in pancreatic cancer: Regulatory mechanisms and future direction. Int J Biol Sci 2021;17:2323-35. [PMID: 34239358 DOI: 10.7150/ijbs.60115] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
31 Mohr T, Katz S, Paulitschke V, Aizarani N, Tolios A. Systematic Analysis of the Transcriptome Profiles and Co-Expression Networks of Tumour Endothelial Cells Identifies Several Tumour-Associated Modules and Potential Therapeutic Targets in Hepatocellular Carcinoma. Cancers (Basel) 2021;13:1768. [PMID: 33917186 DOI: 10.3390/cancers13081768] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Wang J, Chen L, Qiang P. The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers. Cancer Cell Int 2021;21:99. [PMID: 33568150 DOI: 10.1186/s12935-021-01799-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]